Daily Judi: Wednesday, April 12, 2023
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Applied Clinical Trials details the unprecedented suspension by a Texas federal judge of mifepristone, which was approved by the FDA two decades ago.
ABC News has more on the EPA's proposed limit of ethylene oxide, a compound used to sterilize medical devices.
On the New England Journal of Medicine's podcast, “Intention to Treat,” Rachel Gotbaum speaks with Maia Hightower and Isaac Kohane about AI and machine-learning in clinical research and medicine.
Our Culture
“Technology and process improvements will continue to decrease our timelines on creating specifications by 50 percent or more, this year. The more we continue to improve the faster we will be.”
–Jamie, Trial Delivery
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 133,000 users across 171 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 certified collaboration platform.
